We dont know that yet, Schacht said
After a median follow-up of 2.3 years, GLP-1 RAs users exhibit reduced risks of mortality (adjusted hazard ratio [aHR]: 0.57), MACEs (aHR: 0.88), and MAKEs (aHR: 0.73)
ABCC11 is required for the transport of lipophilic substances, bile acids, conjugated steroids, and most importantly the component found in apocrine sweat and earwax, which results in odor and wet earwax
[1] [3] Administered as a once-weekly subcutaneous injection, it works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion in response to elevated blood glucose levels, suppresses glucagon release, and slows gastric emptying